| Description | Sugemalimab, a fully human, full-length, IgG4 monoclonal antibody (mAb) targeting programmed death ligand 1 (PD-L1), exhibits anticancer activities and is applicable in non-small cell lung cancer research [1]. |
| molecular weight | N/A |
| CAS | 2256084-03-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |